Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

HIZENTRA

CSL BEHRING CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of HIZENTRA in Canada?

Yes. HIZENTRA 200MG has an active shortage reported to Health Canada (last updated September 16, 2026).

Why is HIZENTRA not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will HIZENTRA be available again?

The estimated resolution date (September 16, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file6 products
Affected strength200MG
Last updated2026-09-16

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

GAMIMUNE N 10% (IV)

TALECRIS BIOTHERAPEUTICS INC

100MG · DIN 02229695

Different strengthSame dosage formDifferent routeNo current shortage

IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%

TALECRIS BIOTHERAPEUTICS INC

5G · DIN 02230919

Different strengthSame dosage formDifferent routeNo current shortage

HYPERHEP B S/D

GRIFOLS THERAPEUTICS LLC

220UNIT · DIN 02230738

Different strengthSame dosage formDifferent routeNo current shortage

GAMASTAN S/D

GRIFOLS THERAPEUTICS LLC

18% · DIN 02230579

Different strengthSame dosage formDifferent routeNo current shortage

HEPATITIS B IG INJ

CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.

NIL · DIN 00499617

Different strengthDifferent dosage formDifferent routeNo current shortage

GAMIMUNE N INJ 5% (IV)

CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.

50MG · DIN 00559261

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02463067

Strength

200MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

IMMUNOGLOBULIN

See all IMMUNOGLOBULIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History